[{"ATTACHMENTNAME":"cbd6b3d9-58bc-4007-9c28-282cb8e6c77e.pdf","NEWS_DT":"2022-11-15T14:31:36.017","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the earnings conference call for the quarter and half-year ended September 30, 2022 conducted after the meeting of Board of Directors held on November 8, 2022.\r\n\r\nThe above information has been uploaded on the Company''s website at https://www.suvenpharm.com/index.php/investors/financial-info/quarterly-release\r\n\r\nThis ....","SCRIP_CD":543064,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"},{"ATTACHMENTNAME":"c298072f-47d7-44a7-8562-8cdd714cd955.pdf","NEWS_DT":"2022-08-16T11:36:35.85","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the earnings conference call for the quarter ended June 30, 2022 conducted after the meeting of Board of Directors held on August 8, 2022.\r\n\r\nThe above information has been uploaded on the Company''s website at https://www.suvenpharm.com/index.php/investors/financial-info/quarterly-release\r\n\r\nThis ....","SCRIP_CD":543064,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"},{"ATTACHMENTNAME":"b1c9bd20-3e1f-4758-b655-0a140897b9a7.pdf","NEWS_DT":"2022-06-08T12:17:48.18","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Pursuant to Regulation 30 read with Para-A of Part-A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the earnings conference call for the Analyst / Institutional Investor Meeting held on June 1, 2022.\r\n\r\nThe above information has been uploaded on the Company''s website at https://www.suvenpharm.com/index.php/news-events\r\n\r\nThis is for your information and record.","SCRIP_CD":543064,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"},{"ATTACHMENTNAME":"fe7fe75d-c717-494d-b8d2-fd9b8815dd9e.pdf","NEWS_DT":"2022-05-13T15:27:56.24","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the earnings conference call for the quarter and year ended March 31, 2022 conducted after the meeting of Board of Directors held on May 9, 2022.\r\n\r\nThe above information has been uploaded on the Company''s website at https://www.suvenpharm.com/index.php/investors/financial-info/quarterly-release\r\n\r\nThis ....","SCRIP_CD":543064,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"}]